miR-137与miR-195*抑制脑动静脉畸形血管生成
研究对16例样本(含脑动静脉畸形、血管母细胞瘤和对照)行大规模miRNA分析,鉴定出AVM特异性miRNA表达谱,其中miR-137和miR-195*在AVM及AVM平滑肌细胞中显著降低;过表达二者可抑制AVMSMC迁移、成管和存活及体内血管环形成,提示其作为血管生成抑制因子参与AVM发病。
要点
- 脑动静脉畸形中miR-137和miR-195*表达显著降低。
- 过表达miR-137或miR-195*可抑制AVMSMC迁移、成管与存活。
- 二者通过调控血管发育相关信号蛋白抑制异常血管生成。
核心结论
- miR-137和miR-195*是脑动静脉畸形的血管生成抑制因子,其表达缺失导致异常血管生成。
研究设计与样本
- 对16例样本(含AVM、血管母细胞瘤和对照)行大规模miRNA分析以鉴定AVM特异性miRNA表达谱。
- 分离AVM平滑肌细胞(AVMSMC),用流式细胞术和免疫组化鉴定后测试候选miRNA功能。
- 采用迁移、成管和CCK-8增殖实验检测miRNA对AVMSMC表型的影响,并用定量蛋白质组学鉴定miRNA模拟物处理后的蛋白表达变化。
主要发现
- AVM存在以大量低表达miRNA为特征的特异性miRNA表达谱。
- miR-137和miR-195*在AVM及AVMSMC中水平显著降低。
- 实验性升高miR-137或miR-195*可抑制AVMSMC体外迁移、成管和存活及体内血管环形成。
- 蛋白质组学鉴定出受miR-137和miR-195*调控的血管发育关键信号蛋白。
临床怎么用
- miR-137和miR-195*可能作为脑动静脉畸形血管生成干预的候选靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Brain arteriovenous malformations (AVMs) are the most common cause of nontraumatic intracerebral hemorrhage in young adults. The genesis of brain AVM remains enigmatic. We investigated microRNA (miRNA) expression and its contribution to the pathogenesis of brain AVMs. METHODS: We used a large-scale miRNA analysis of 16 samples including AVMs, hemangioblastoma, and controls to identify a distinct AVM miRNA signature. AVM smooth muscle cells (AVMSMCs) were isolated and identified by flow cytometry and immunohistochemistry, and candidate miRNAs were then tested in these cells. Migration, tube formation, and CCK-8-induced proliferation assays were used to test the effect of the miRNAs on phenotypic properties of AVMSMCs. A quantitative proteomics approach was used to identify protein expression changes in AVMSMCs treated with miRNA mimics. RESULTS: A distinct AVM miRNA signature comprising a large portion of lowly expressed miRNAs was identified. Among these miRNAs, miR-137 and miR-195* levels were significantly decreased in AVMs and constituent AVMSMCs. Experimentally elevating the level of these microRNAs inhibited AVMSMC migration, tube formation, and survival in vitro and the formation of vascular rings in vivo. Proteomics showed the protein expression signature of AVMSMCs and identified downstream proteins regulated by miR-137 and miR-195* that were key signaling proteins involved in vessel development. INTERPRETATION: Our results indicate that miR-137 and miR-195* act as vasculogenic suppressors in AVMs by altering phenotypic properties of AVMSMCs, and that the absence of miR-137 and miR-195* expression leads to abnormal vasculogenesis. Ann Neurol 2017;82:371-384.
引用
- Huang J, Song J, Qu M, et al. MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations. Ann Neurol. 2017. PMID: 28802071. doi:10.1002/ana.25015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。